8 withdrawn. 8 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Withdrawn 8 |
| Phase 1 | 2 | Withdrawn 2 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TCR Alpha/Beta and CD19-deplete Haplo-HSCT CliniMACS Plus Instrument - Pediatric Patients, Hematologic Malignancy | Phase 2 | Withdrawn | University of Colorado, Denver | 2024-12-01 | 2024-10-18 | |
| CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies CliniMACS, Bone Marrow Transplant, Hyperfractionated Total Body Irradiation - Hematologic Diseases, Hematologic Malignancy | Phase 2 | Withdrawn | Baptist Health South Florida | 2022-09-01 | 2022-09-27 | |
| Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies Hematopoietic Stem Cells from HLA-compatible Related, Hematopoietic Stem Cells from HLA Unrelated - B-Cell Lymphoid Malignancies, Hematologic Malignancy | Phase 2 | Withdrawn | Baptist Health South Florida | 2022-03-28 | 2023-11-01 | |
| MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation MPH966, Placebo - Hematologic Malignancy | Phase 1 / Phase 2 | Withdrawn | Nelson Chao | 2021-09-01 | 2020-03-20 | |
| Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) Hydroxychloroquine Sulfate 200 MG [Plaquenil], Azithromycin 250 MG Oral Capsule, Placebo oral tablet - COVID19, Hematologic Malignancy | Phase 2 | Withdrawn | Institut de cancérologie Strasbourg Europe | 2020-09-02 | 2020-09-04 | |
| Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies Fludarabine, Cytarabine, Erwinase - Hematologic Malignancy | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2018-05-01 | 2018-06-26 | |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies Treg cells, CD3+ Teff cells, Fludarabine - Hematologic Malignancy, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Withdrawn | Masonic Cancer Center, University of Minnesota | 2014-01-01 | 2017-12-02 | |
| Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation TXA127 - Cord Blood Transplant, Hematologic Malignancy | Phase 2 | Withdrawn | Tarix Pharmaceuticals | 2012-03-01 | 2016-08-31 |
Hematologic Neoplasms (8) · Leukemia, Myeloid, Acute (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Burkitt Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Anemia, Refractory, with Excess of Blasts (1) · COVID-19 (1) · Hematologic Diseases (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Prolymphocytic (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1)
Hemic and Lymphatic Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Hematologic Diseases (7) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms by Histologic Type (4) · Disease Attributes (3) · Infections (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Leukemia, Myeloid (3) · Pathologic Processes (3)
fludarabine (3) · Cyclophosphamide (2) · fludarabine phosphate (2) · Asparaginase (1) · Azithromycin (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Cord Blood Stem Cell Transplantation (1) · Cytarabine (1) · Hydroxychloroquine (1) · Melphalan (1) · Thiotepa (1) · Whole-Body Irradiation (1) · angiotensin I (1-7) (1) · asparaginase erwinia chrysanthemi recombinant (1)
Baptist Health South Florida (2) · Institut de cancérologie Strasbourg Europe (1) · M.D. Anderson Cancer Center (1) · Masonic Cancer Center, University of Minnesota (1) · Nelson Chao (1) · Tarix Pharmaceuticals (1) · University of Colorado, Denver (1)
United States (5) · France (1)
Alisa B Lee Sherick (1) · Anthony Sung, MD (1) · Claudio Brunstein, MD, PhD (1) · Guenther Koehne, MD (1) · Guenther Koehne, MD, PhD (1) · Joanne Kurtzberg, MD (1) · Kristin Page, MD (1) · Tapan Kadia, MD (1)